Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2018-11-08 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
107年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 107年09月30日 (which corresponds to the third quarter of the fiscal year 2018). The content includes actual financial figures for assets, liabilities, and equity, indicating it is a substantive financial report. The length is 3674 characters, which is relatively short but contains detailed financial data rather than just an announcement or a link to a report. The presence of quarterly financial data and the date suggests this is an Interim / Quarterly Report rather than a full Annual Report or just an announcement. There is no indication that this is a certification, announcement, or other type of filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2018
2018-11-08 Chinese
107年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity, including items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data covers a specific period (the first three quarters of the 107th year in the ROC calendar, which corresponds to 2018) and compares it with the same period in the previous year. The document is 3755 characters long, which is relatively short but contains substantive financial data rather than just an announcement or a certification. The content is consistent with a financial report for a period shorter than a full fiscal year, specifically an interim or quarterly report. There is no indication that this is an announcement of a report, a certification, or a regulatory filing. Therefore, the document should be classified as an Interim / Quarterly Report (IR). 9M 2018
2018-11-08 Chinese
107年10月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, supervisors, managers, and their related parties. It includes data on shares held at appointment, changes during the month, and current holdings. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions by company directors and executives (insider trades). Therefore, the appropriate classification is Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification.
2018-11-05 Chinese
107年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and managers, with specific numbers of shares held and pledged. It is focused on insider shareholdings and related disclosures. There is no indication of financial results, earnings, management discussion, or regulatory certifications. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters and is not an announcement of a report but a direct disclosure of insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2018-11-05 Chinese
107年9月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a summary report of monthly and cumulative operating revenue figures for a company named 科妍, with data presented in New Taiwan Dollars for the period 民國107年09月 (September 2018). It includes percentage changes compared to the previous year and notes on accounting standards (IFRS) and reporting requirements. The document is very short (764 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It is essentially a brief financial data summary or factsheet rather than a full report or announcement. Therefore, it fits best into the category of Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2018-10-09 Chinese
107年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (科妍) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains tabulated financial data but is very short (601 characters) and focuses on specific financial information related to guarantees and loans rather than comprehensive financial statements or management discussion. This type of disclosure is typical of regulatory filings that provide compliance or financial status updates without constituting a full financial report. There is no indication that this is an annual or interim report, audit report, or other specific report type. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2018-10-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.